KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Other financing activities (2017)

Historic Other financing activities for Pacira BioSciences (PCRX) over the last 5 years, with Q1 2017 value amounting to $11.0 million.

  • Pacira BioSciences' Other financing activities changed N/A to $11.0 million in Q1 2017 from the same period last year, while for Dec 2017 it was $11.0 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2022, which is 7415.31% down from last year.
  • Pacira BioSciences' Other financing activities amounted to $11.0 million in Q1 2017.
  • Pacira BioSciences' Other financing activities' 5-year high stood at $11.0 million during Q1 2017, with a 5-year trough of $7.2 million in Q1 2013.